MDM2 adenovirus

The MDM2 gene, also known as murine double minute 2 homolog, is a key regulator in cellular processes, primarily known for its role in the p53 tumor suppressor pathway. Located on human chromosome 12, the MDM2 gene encodes an E3 ubiquitin ligase that targets the p53 protein for proteasomal degradation, thereby controlling p53 activity in cellular stress responses. This negative feedback loop ensures that p53-mediated functions, such as DNA repair, cell cycle arrest, and apoptosis, are tightly regulated to prevent uncontrolled cell proliferation. Dysregulation of MDM2, often due0 to gene amplification or overexpression, is closely associated with the development and progression of various cancers because it leads to the suppression of p53 tumor suppressor function. Therefore, MDM2 has become a promising therapeutic target, and inhibitors aimed at disrupting the MDM2-p53 interaction and restoring p53 activity in cancer cells are currently under development.

MDM2 adenovirus refers to genetically engineered adenoviral vectors used to modulate MDM2 expression or function for research or therapeutic purposes. Adenoviruses are commonly used in gene therapy due to their high transduction efficiency, broad host range, and ability to carry large gene fragments. MDM2 adenoviruses are crucial for studying the role of MDM2 in tumorigenesis, cell cycle regulation, and therapeutic resistance. Furthermore, MDM2 adenoviruses have been used in cancer gene therapy strategies aimed at reactivating p53 by inhibiting MDM2 or directly targeting tumors with MDM2 overexpression. Despite challenges such as immunogenicity and transient expression, adenovirus-based approaches remain a versatile platform for advancing MDM2-related biomedical research.